<?xml version="1.0" encoding="UTF-8"?>
<fig id="F6" orientation="portrait" position="float">
 <label>Figure 6.</label>
 <caption>
  <p>CPC formulation (ARMS-I, 0.1% CPC w/v) reduced influenza-associated pathogenicity 
   <italic>in vivo</italic>. ARMS-I prophylactic protection from morbidity and mortality was demonstrated by (A) body weight (percentage of initial weight on Day 0) and (B) Kaplan-Meier survival curve, respectively. The ARMS-I and oseltamivir groups were treated 15 minutes before the challenge and then twice a day for 5 consecutive days.
  </p>
 </caption>
 <graphic xlink:href="pai-2-253-g006" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
